To further examine whether LRRC15+ MSCs possess therapeutic function, we performed cell transplantation in a bleomycin-induced pulmonary fibrosis (BPF) model, which is one of the most established drug-inducible disease models. This evidence concerns the gene LRRC15 and pulmonary fibrosis.